ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
How to invest
$20,000 invested in these ASX 200 shares 10 years ago is now worth… (a lot!)
Healthcare Shares
2 ASX healthcare shares to buy now for the AI revolution
Growth Shares
4 ASX growth shares to buy to supercharge your portfolio in June
Growth Shares
2 no-brainer ASX 200 shares to buy next week
Best Shares
4 ASX shares held by billionaire fund managers
Broker Notes
ResMed shares higher as company 'turns the GLP threat into an opportunity': Fundie
Healthcare Shares
Buy, hold or sell these 3 ASX 200 healthcare shares: Experts
Blue Chip Shares
2 of the best ASX 200 blue-chip shares to buy in May
Healthcare Shares
3 reasons ResMed shares 'are just too cheap!'
Investing Strategies
4 founder-led ASX 300 shares that have helped this fund outperform
Healthcare Shares
Resmed share price higher despite CEO hitting sell on 14,683 shares
Broker Notes
Morgans names more of the best ASX 200 shares to buy in May
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
